Skip to main content
. 2024 Nov 12;11:1458560. doi: 10.3389/fnut.2024.1458560

Table 1.

The baseline characteristics of study population across quartiles of total, plant, animal and the ratio of plant to animal protein intake (n = 479).

Characteristics, mean
(SD) or N (%)
Total protein p-value Plant protein P-value Animal protein P the ratio of plant to animal protein P-value
Q1 (n = 119) Q4 (n = 119) Q1 (n = 119) Q4 (n = 120) Q1 (n = 119) Q4 (n = 120) Q1 (n = 119) Q4 (n = 120)
BMI 24.85 ± 5.63 24.28 ± 5.43 0.52 24.0 ± 5.0 24.0 ± 5.0 0.61 25 ± 4 24 ± 5 0.30 24.06 ± 5.28 24.74 ± 4.90 0.34
Age, year 58.18 ± 14.25 48.09 ± 15.04 <0.001 56 ± 14 49 ± 15 <0.001 56 ± 14 49 ± 14 <0.001 52.0 ± 14.0 53.0 ± 14.0 0.29
Frequency dialysis per week, time/week 2.91 ± 0.60 2.79 ± 0.42 0.34 2.90 ± 0.59 2.77 ± 0.47 0.20 2.85 ± 0.54 2.78 ± 0.43 0.36 2.83 ± 0.55 2.80 ± 0.45 0.28
Dialysis time, hours 3.69 ± 0.46 3.65 ± 0.54 0.82 3.66 ± 0.49 3.70. ± 0.46 0.75 3.70 ± 0.47 3.65 ± 0.56 0.82 3.61 ± 0.52 3.69 ± 0.40 0.21
Fluid intake, mL 1071.47 ± 738.27 1368.17 ± 1026.38 0.03 1,037 ± 726 1,502 ± 1,489 <0.001 1,196 ± 902 1,226 ± 714 0.39 1,062 ± 764 1,302 ± 1,379 0.27
PA, met-min/wk 177.62 ± 361.60 863.15 ± 2898.92 0.07 400 ± 2,554 653 ± 1,500 0.49 199 ± 414 682 ± 2,696 0.35 576 ± 2,695 256 ± 473 0.21
Physical activity, N (%) 0.10 0.20 0.41 0.11
Low 107 (89) 87 (73) 107 (89) 87 (73) 104 (87) 94 (78) 102 (85) 99 (82)
Moderate 12 (10) 27 (23) 11 (9) 29 (24) 15 (12) 23 (19) 14 (11) 21 (17)
High 0 (0) 5 (5) 0 (0) 4 (3) 0 (0) 3 (2) 3 (2) 0 (0)
Center type (N) (%) 0.93 0.28 0.28 0.21
Governmental 78 (65) 75 (63) 82 (68) 73 (60) 76 (63) 80 (66) 82 (68) 68 (56)
Private 41 (34) 44 (36) 37 (31.1) 47 (39) 43 (36) 40 (33) 37 (31.1) 52 (43)
Male (N) (%) 49 (41) 93 (78) <0.001 47 (39) 93 (77) <0.001 58 (69) 89 (74) <0.001 70 (58) 70 (58) 0.99
SMOKER (N) (%) 7(5) 46 (9) 0.12 7 (5) 15 (12) 0.37 7 (5) 17 (14) 0.18 12 (10) 8 (6) 0.49
Urine volume, 500 mL > 94 (78) 79 (66) 0.04 94 (78) 74 (61) 0.01 89 (74) 75 (62) 0.04 83 (69) 84 (70) 0.77
Diabetes (n, %) 59 (49) 40 (33) 0.05 82 (68) 83 (69) 0.02 53 (44) 45 (37) 0.14 57 (47) 53 (44) 0.69
Hypertension (n, %) 87 (73) 86 (72) 0.61 82 (68) 83 (69) 0.04 93 (78) 94 (78) 0.18 89 (74) 92 (976) 0.94
Job, N (%) <0.001 <0.001 0.002 0.95
Unemployed 14 (11) 23 (19) 15 (12) 26 (21) 18 (15) 24 (20) 18 (15) 18 (15)
Housekeeper 62 (52) 23 (19) 65 (54) 26 (21) 54 (45) 26 (21) 41 (33) 46 (38)
Retired 27 (22) 23 (19) 24 (20) 26 (21) 27 (22) 22 (18) 27 (22) 28 (23)
Employee 6 (5) 17 (14) 3 (2) 15 (12) 7 (5) 11 (9) 7 (5) 11 (9)
Self-employment 7 (5) 24 (20) 9 (7) 21 (17) 9 (7) 25 (20) 18 (15) 13 (10)
Others 3 (2) 9 (7) 3 (2) 6 (5) 4 (3) 12 (10) 8 (6) 4 (3)
Marital status, N (%) 0.004 0.12 0.006 0.61
Married 97 (81) 85 (71) 94 (78) 83 (69) 96 (80) 89 (73) 87 (73) 94 (78)
Single 11 (9) 26 (21) 14 (11) 23 (19) 12 (10.1) 22 (18) 20 (16) 18 (15)
Divorced 3 (2) 7 (5) 4 (3) 4 (3) 1 (0) 9 (7) 8 (6) 3 (2)
Dead spouse 8 (6) 1 (0) 7 (5) 7 (5) 10 (8) 1 (0) 4 (3) 5 (4)
Education, N (%) 0.01 0.15 0.16 0.52
<12 years 100 (84) 84 (70) 99 (83) 87 (72) 102 (85) 89 (74) 92 (77) 96 (80)
≥12 years 19 (15) 35 (29) 20 (16) 33 (27) 17 (14) 31 (25) 27 (22) 24 (20)
Income status, N (%) 0.39 0.77 0.14 0.60
<5 million rials 45 (37) 39 (32) 41 (34) 38 (31) 41 (34) 40 (33) 43 (36) 38 (31)
5–10 million rials 45 (37) 37 (31.1) 49 (41) 42 (35) 57 (47) 43 (35) 40 (33) 47 (39)
10–20 million rials 24 (20) 32 (26) 25 (21) 31 (25) 17 (14) 26 (21) 28 (23) 28 (23)
>20 million rials 5 (4) 11 (9) 4 (3) 9 (7) 4 (3) 11 (9) 8 (6) 7 (5)
Medication prescriptions
Calcium carbonate 500 mg, time/day 1.19 ± 1 1.06 ± 1.80 0.29 1.12 ± 1.75 1.27 ± 1.71 0.29 1.26 ± 1.82 1.02 ± 1.60 0.32 1.04 ± 1.51 1.40 ± 1.78 0.27
Sevelamer hydrochloride 800 mg, time/day 0.70 ± 1.18 0.87 ± 1.49 0.55 0.67 ± 1.19 0.84 ± 1.46 0.34 0 ± 1 0 ± 1 0.78 0.84 ± 1.32 0.91 ± 1.55 0.04
Calcitriol 0.25 mcg, time/day 0.61 ± 0.98 0.50 ± 1.00 0.14 0.72 ± 1.13 0.67 ± 1.14 0.94 0 ± 1.03 0 ± 1.00 0.46 0.57 ± 1.01 0.60 ± 1.01 0.09
Furosemide time/day 0.35 ± 0.83 0.39 ± 0.93 0.49 0.42 ± 0.89 0.23 ± 0.61 0.04 0 ± 0 0 ± 1.06 0.21 0.46 ± 0.98 0.25 ± 0.68 0.19
Corticosteroids, N (%) 7 (5) 3 (2) 0.62 7 (5) 4 (3) 0.46 4 (3) 4 (3) 0.29 7 (5) 5 (4) 0.80
Lipid-lowering drugs, N (%) 26 (21) 13 (10) 0.07 28 (23) 14 (11) 0.06 22 (18) 17 (14) 0.54 23 (19) 20 (16) 0.93
Kt/V 1.31 ± 0.56 1.15 ± 0.42 0.01 1.28 ± 0.53 1.13 ± 0.4 0.006 1.32 ± 0.61 1.14 ± 0.41 0.02 1.22 ± 0.55 1.27 ± 0.52 0.83
URR (%) 34.09 ± 31.57 40.79 ± 30.11 0.26 36.11 ± 30.62 36.55 ± 30.05 0.84 32.65 ± 31.34 41.28 ± 29.38 0.16 38.95 ± 30.3 33.61 ± 31.48 0.50

Data for quantitative variables are presented as means ± SD, obtained from ANOVA. Data for qualitative variables are presented as frequencies (percentages) and analyzed using chi-square tests. PA, physical activity; BMI, body mass index.